NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology company developing innovative medicines and […]
Expediting Treatment of COVID-19 Patients and Enhancing Testing Resources for Caregivers in OklahomaWorkflow from Extraction through Real-Time PCR Using Fluidigm […]